Peter U. Park

Antibody-Maytansinoid Conjugates Are Activated in Targeted Cancer Cells by Lysosomal Degradation and Linker-Dependent Intracellular Processing

Hans K. Erickson, Peter U. Park, Wayne C. Widdison et al. · Cancer Research · 2006 · 574 citations · Full text

Medicine, Oncology, Pharmacology +14

SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

Jutta Deckert, Marie-Cécile Wetzel, Laura M. Bartle et al. · Clinical Cancer Research · 2014 · 329 citations

Medicine, Oncology, Pharmacology +17

<i>In vivo</i> depletion of CD4⁺FOXP3⁺ Treg cells by the PC61 anti‐CD25 monoclonal antibody is mediated by FcγRIII⁺ phagocytes

Yulius Y. Setiady, Jennifer A. Coccia, Peter U. Park · European Journal of Immunology · 2009 · 213 citations

Life Sciences, Cell Biology, Immunology +11

Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria

Damien Arnoult, Laura M. Bartle, Anna Skaletskaya et al. · Proceedings of the National Academy of Sciences · 2004 · 196 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Effects of Mutations in DNA Repair Genes on Formation of Ribosomal DNA Circles and Life Span in <i>Saccharomyces cerevisiae</i>

Peter U. Park, Pierre‐Antoine Defossez, Leonard Guarente · Molecular and Cellular Biology · 1999 · 157 citations · Full text

Life Sciences, Biology, Genetics +17